Member Exclusive

Cell therapy weekly: Representatives reject 'right to try' and Duchenne trial placed on hold

This week: US House of Representatives votes against tabled 'right to try' bill and a new treatment for osteoarthritis receives RMAT designation.

Go to the profile of RegMedNet
Mar 15, 2018
1
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.